JP2008513370A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513370A5
JP2008513370A5 JP2007531465A JP2007531465A JP2008513370A5 JP 2008513370 A5 JP2008513370 A5 JP 2008513370A5 JP 2007531465 A JP2007531465 A JP 2007531465A JP 2007531465 A JP2007531465 A JP 2007531465A JP 2008513370 A5 JP2008513370 A5 JP 2008513370A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
disorder
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007531465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513370A (ja
Filing date
Publication date
Priority claimed from US10/940,269 external-priority patent/US20050209300A1/en
Priority claimed from US11/077,664 external-priority patent/US20060074124A1/en
Application filed filed Critical
Publication of JP2008513370A publication Critical patent/JP2008513370A/ja
Publication of JP2008513370A5 publication Critical patent/JP2008513370A5/ja
Pending legal-status Critical Current

Links

JP2007531465A 2004-09-13 2005-09-13 障害を処置する方法 Pending JP2008513370A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/940,269 US20050209300A1 (en) 2003-09-12 2004-09-13 Methods of treating a disorder
US11/077,664 US20060074124A1 (en) 2003-09-12 2005-03-11 Methods of treating a disorder
PCT/US2005/032760 WO2006031894A2 (en) 2004-09-13 2005-09-13 Methods of treating a disorder

Publications (2)

Publication Number Publication Date
JP2008513370A JP2008513370A (ja) 2008-05-01
JP2008513370A5 true JP2008513370A5 (https=) 2008-09-18

Family

ID=36060677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531465A Pending JP2008513370A (ja) 2004-09-13 2005-09-13 障害を処置する方法

Country Status (7)

Country Link
US (4) US20060074124A1 (https=)
EP (1) EP1793817A4 (https=)
JP (1) JP2008513370A (https=)
AU (1) AU2005284851A1 (https=)
CA (1) CA2578355A1 (https=)
MX (1) MX2007002816A (https=)
WO (1) WO2006031894A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
US20090022694A1 (en) * 2005-10-18 2009-01-22 Distefano Peter Sirt1 inhibition
CN105481788A (zh) * 2006-10-28 2016-04-13 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
WO2008054767A2 (en) * 2006-10-30 2008-05-08 University Of Southern California N4 modifications of pyrimidine analogs and uses thereof
WO2008060400A2 (en) * 2006-11-15 2008-05-22 Sirtris Pharmaceuticals, Inc. Sirtuin polymorphisms and methods of use thereof
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
CN101687010A (zh) * 2006-12-29 2010-03-31 格洛斯特制药公司 制备Romidepsin
AU2007342028B2 (en) * 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
WO2008119070A1 (en) * 2007-03-28 2008-10-02 Trustees Of Boston University Methods of treatment using sirt modulators and compositions containing sirt1 modulators
EA019713B1 (ru) * 2008-05-16 2014-05-30 Эли Лилли Энд Компани ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛЬНЫЕ МОДУЛЯТОРЫ РЕЦЕПТОРОВ АНДРОГЕНОВ
WO2010077642A1 (en) 2008-12-08 2010-07-08 Northwestern University Method of modulating hsf-1
US8318928B2 (en) * 2008-12-15 2012-11-27 Glenmark Pharmaceuticals, S.A. Fused imidazole carboxamides as TRPV3 modulators
JP2012076998A (ja) * 2009-01-29 2012-04-19 Sapporo Medical Univ メラノーマの転移抑制剤
BRPI1014821A2 (pt) * 2009-04-09 2016-04-05 Boehringer Ingelheim Int "inibidores de replicação de hiv"
TW201500358A (zh) 2010-12-16 2015-01-01 赫夫門羅氏藥廠股份有限公司 三環ｐｉ３ｋ抑制劑化合物及其使用方法
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
DK2911650T3 (da) * 2012-10-29 2019-11-18 Agency Science Tech & Res Hidtil ukendt reagens til gen-lægemiddel-terapeutika
EP3230279A1 (en) 2014-12-10 2017-10-18 Massachusetts Institute of Technology Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
US9745253B2 (en) 2015-03-13 2017-08-29 Forma Therapeutics, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
KR20180107261A (ko) 2016-02-16 2018-10-01 메사추세츠 인스티튜트 오브 테크놀로지 Myc 조정제로서의 MAX 결합제 및 그의 용도
CA3068005A1 (en) * 2017-06-19 2018-12-27 The Board Of Trustees Of The Leland Stanford Junior University Compounds for the reduction of the deleterious activity of extended nucleotide repeat containing genes
WO2020083933A1 (en) * 2018-10-23 2020-04-30 Mexav Biotech Ag Fusion polypeptides and therapeutic applications thereof
PY2438446A (es) * 2023-05-16 2025-06-18 Aop Orphan Ip Ag Preparación de (s)-6-cloro-2,3,4,9- tetrahidro-1h-carbazol-1-carboxamida en forma enantioméricamente enriquecida mediante proceso de resolución
CN120118019A (zh) * 2023-12-08 2025-06-10 苏州湃芮生物科技有限公司 一种RNA m6A调控剂的共晶形式及其制备方法与应用
CN120136769A (zh) * 2023-12-11 2025-06-13 苏州湃芮生物科技有限公司 一种RNA m6A调控剂的结晶形式及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769298A (en) * 1971-04-02 1973-10-30 Pfizer Substituted aminomethylcarbazoles
BE793493A (fr) * 1971-12-30 1973-06-29 Hoffmann La Roche Composes tricycliques
DE2226703A1 (de) * 1972-05-25 1973-12-13 Schering Ag Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
US4009181A (en) * 1973-01-22 1977-02-22 Hoffmann-La Roche Inc. Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof
US4057640A (en) * 1973-07-18 1977-11-08 Schering Aktiengesellschaft 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives
BG25793A3 (bg) * 1973-07-18 1978-12-12 Schering Aktiengesellschaft Метод за получаване на карбазолови деривати
DE2431292A1 (de) 1974-06-27 1976-01-15 Schering Ag Neue carbazol-derivate
HUT76923A (hu) * 1994-07-27 1998-01-28 Sankyo Company Limited Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
JP2000508302A (ja) * 1996-04-04 2000-07-04 エフ．ホフマン―ラ ロッシュ エイジー 抗転移剤としてのテトラヒドロ―β―カルボリン誘導体の使用
US5830911A (en) * 1996-08-14 1998-11-03 American Home Products Corporation Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
WO2000002878A1 (en) * 1998-07-11 2000-01-20 University Of Bristol Compounds having activity at imidazoline receptors
US20010039012A1 (en) * 1999-06-14 2001-11-08 Lapidus Stanley N. Methods for diagnostic screening
WO2002102981A2 (en) * 2001-06-15 2002-12-27 The Trustees Of Columbia University In The City Of New York SIR2α-BASED THERAPEUTIC AND PROPHYLACTIC METHODS
WO2003051837A2 (de) * 2001-12-14 2003-06-26 Zentaris Gmbh Tetrahydrocarbazolderivate als liganden für g-protein gekoppelte rezeptoren (gpcr)
CA2473740A1 (en) * 2002-01-18 2003-07-31 David Solow-Cordero Methods of treating conditions associated with an edg receptor
CA2509607A1 (en) * 2002-12-13 2004-07-01 Elixir Pharmaceuticals, Inc. Cytochrome c acetylation
US20050137220A1 (en) * 2003-07-23 2005-06-23 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
EP1677794B1 (en) * 2003-09-12 2014-12-03 Elixir Pharmaceuticals, Inc. Methods of treating disorder
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
JP2007515429A (ja) * 2003-12-19 2007-06-14 エリクシアー ファーマシューティカルズ， インコーポレイテッド 障害を治療する方法
EP1734950A4 (en) * 2004-01-29 2010-06-16 Elixir Pharmaceuticals Inc TREATMENT OF A VIRUS DISEASE

Similar Documents

Publication Publication Date Title
JP2008513370A5 (https=)
JP2007505148A5 (https=)
JP2007515429A5 (https=)
JP2009530399A5 (https=)
JP2004523582A5 (https=)
EP2371811A3 (en) Azetidinecarboxylic acid derivative and medicinal use thereof
JP2009514837A5 (https=)
JP2012530779A5 (https=)
JP2010514829A5 (https=)
JP2003523996A5 (https=)
JP2010526145A5 (https=)
MY156747A (en) Isoxazolo-pyridine derivatives
JP2008521829A5 (https=)
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
JP2020502092A5 (https=)
JP2012508734A5 (https=)
JP2018530582A5 (https=)
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
US7772206B2 (en) Methods and compositions for the treatment of autoimmune disorders using clofarabine
WO2008088039A1 (ja) ドネペジルを含有する安定化医薬組成物、その製造方法、及び安定化方法
US20090062263A1 (en) 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
RU2014123784A (ru) Новые производные пирролидина в качестве ингибиторов катепсина
JP2017510645A5 (https=)
JP2007519743A5 (https=)
JP2017503804A5 (https=)